Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Neoplasms of the CNS

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 68 articles:
HTML format
Text format



Single Articles


    October 2019
  1. PRINTZ C
    Some elderly survivors of 3 common cancers have an increased risk of brain metastases.
    Cancer. 2019;125:3286-3287.
    PubMed     Text format    


    August 2019
  2. OFFIN M, Feldman D, Ni A, Myers ML, et al
    Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers.
    Cancer. 2019 Aug 30. doi: 10.1002/cncr.32461.
    PubMed     Text format     Abstract available


  3. SCHVARTSMAN G, Ma J, Bassett RL Jr, Haydu LE, et al
    Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
    Cancer. 2019 Aug 9. doi: 10.1002/cncr.32454.
    PubMed     Text format     Abstract available


    July 2019
  4. JURATLI TA, Jones PS, Wang N, Subramanian M, et al
    Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.
    Cancer. 2019 Jul 17. doi: 10.1002/cncr.32197.
    PubMed     Text format    


  5. GALANIS E, Anderson SK, Twohy EL, Carrero XW, et al
    A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872.
    Cancer. 2019 Jul 10. doi: 10.1002/cncr.32340.
    PubMed     Text format     Abstract available


  6. RULLI E, Legramandi L, Salvati L, Mandala M, et al
    The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis.
    Cancer. 2019 Jul 9. doi: 10.1002/cncr.32375.
    PubMed     Text format     Abstract available


  7. WANG H, Ou Q, Li D, Qin T, et al
    Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
    Cancer. 2019 Jul 9. doi: 10.1002/cncr.32372.
    PubMed     Text format     Abstract available


    June 2019
  8. BACK MF, Jayamanne D, Back E, Kastelan M, et al
    Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma.
    Cancer. 2019 Jun 28. doi: 10.1002/cncr.32352.
    PubMed     Text format     Abstract available


  9. RIS MD, Leisenring WM, Goodman P, Di C, et al
    Neuropsychological and socioeconomic outcomes in adult survivors of pediatric low-grade glioma.
    Cancer. 2019 Jun 24. doi: 10.1002/cncr.32186.
    PubMed     Text format     Abstract available


  10. COTE DJ, Ostrom QT, Gittleman H, Duncan KR, et al
    Glioma incidence and survival variations by county-level socioeconomic measures.
    Cancer. 2019 Jun 17. doi: 10.1002/cncr.32328.
    PubMed     Text format     Abstract available


    May 2019
  11. PRINTZ C
    First person profile: Michelle Monje, MD, PhD: Her research on how normal brain functions contribute to pediatric brain tumors may help physicians fight a lethal childhood cancer.
    Cancer. 2019;125:1397-1398.
    PubMed     Text format    


    February 2019
  12. MARAKA S, Groves MD, Penas-Prado M
    Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
    Cancer. 2019 Feb 1. doi: 10.1002/cncr.31960.
    PubMed     Text format    


  13. NEVIN RL
    Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
    Cancer. 2019 Feb 1. doi: 10.1002/cncr.31961.
    PubMed     Text format    


    January 2019
  14. PRINTZ C
    Pediatric computed tomography scans: Weighing the risks and benefits: A new study suggests that computed tomography-related radiation may increase the risk of brain tumors, but the conversation, physicians say, is complex-and far from settled.
    Cancer. 2019;125:171-173.
    PubMed     Text format    


  15. LIU APY, Hastings C, Wu S, Bass JK, et al
    Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.
    Cancer. 2019 Jan 8. doi: 10.1002/cncr.31918.
    PubMed     Text format     Abstract available


    December 2018
  16. GEURTS M, van den Bent MJ
    On high-risk, low-grade glioma: What distinguishes high from low?
    Cancer. 2018 Dec 4. doi: 10.1002/cncr.31834.
    PubMed     Text format    


    November 2018
  17. PRINTZ C
    Can a repurposed vaccine fight cancer?: Use of the poliovirus vaccine to target brain tumors draws interest.
    Cancer. 2018;124:4273-4274.
    PubMed     Text format    


    October 2018
  18. MARAKA S, Groves MD, Mammoser AG, Melguizo-Gavilanes I, et al
    Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31811.
    PubMed     Text format     Abstract available


  19. YEH TC, Liang DC, Hou JY, Jaing TH, et al
    Treatment of childhood acute lymphoblastic leukemia with delayed first intrathecal therapy and omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002 study.
    Cancer. 2018 Oct 10. doi: 10.1002/cncr.31758.
    PubMed     Text format     Abstract available


    September 2018
  20. KUMAR R, Liu APY, Orr BA, Northcott PA, et al
    Advances in the classification of pediatric brain tumors through dna methylation profiling: from research tool to frontline diagnostic.
    Cancer. 2018 Sep 26. doi: 10.1002/cncr.31583.
    PubMed     Text format     Abstract available


    August 2018
  21. PRESS RH, Zhang C, Cassidy RJ, Ferris MJ, et al
    Targeted Sequencing and Intracranial Outcomes of Patients With Lung Adenocarcinoma Brain Metastases Treated With Radiotherapy.
    Cancer. 2018 Aug 18. doi: 10.1002/cncr.31589.
    PubMed     Text format     Abstract available


    June 2018
  22. KAMRAN SC, Goldberg SI, Kuhlthau KA, Lawell MP, et al
    Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up.
    Cancer. 2018 Jun 15. doi: 10.1002/cncr.31575.
    PubMed     Text format     Abstract available


    April 2018
  23. WICK W, Winkler F
    Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.
    Cancer. 2018 Apr 26. doi: 10.1002/cncr.31371.
    PubMed     Text format    


    March 2018
  24. UEMURA MI, French JT, Hess KR, Liu D, et al
    Development of CNS metastases and survival in patients with inflammatory breast cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31336.
    PubMed     Text format     Abstract available


  25. LEHRER S, Rheinstein PH, Rosenzweig KE
    Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.
    Cancer. 2018 Mar 15. doi: 10.1002/cncr.31262.
    PubMed     Text format    


  26. SLOOT S, Chen YA, Zhao X, Weber JL, et al
    Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.
    Cancer. 2018 Mar 15. doi: 10.1002/cncr.31261.
    PubMed     Text format    


  27. ZUREICK AH, Evans CL, Niemierko A, Grieco JA, et al
    Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors.
    Cancer. 2018 Mar 2. doi: 10.1002/cncr.31143.
    PubMed     Text format     Abstract available


    January 2018
  28. WELLER M
    Where does O(6) -methylguanine DNA methyltransferase promoter methylation assessment place temozolomide in the future standards of care for glioblastoma?
    Cancer. 2018 Jan 30. doi: 10.1002/cncr.31244.
    PubMed     Text format    


  29. SCHIFF D, Jaeckle KA, Anderson SK, Galanis E, et al
    Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.
    Cancer. 2018 Jan 3. doi: 10.1002/cncr.31219.
    PubMed     Text format     Abstract available


  30. WANG N, Bertalan MS, Brastianos PK
    Leptomeningeal metastasis from systemic cancer: Review and update on management.
    Cancer. 2018;124:21-35.
    PubMed     Text format     Abstract available


    December 2017
  31. REARDON DA, Lassman AB, Schiff D, Yunus SA, et al
    Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
    Cancer. 2017 Dec 19. doi: 10.1002/cncr.31172.
    PubMed     Text format     Abstract available


  32. JHAVERI J, Liu Y, Chowdhary M, Buchwald ZS, et al
    Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
    Cancer. 2017 Dec 4. doi: 10.1002/cncr.31158.
    PubMed     Text format     Abstract available


    November 2017
  33. GEORGAKIS MK, Papathoma P, Ryzhov A, Zivkovic-Perisic S, et al
    Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
    Cancer. 2017;123:4458-4471.
    PubMed     Text format     Abstract available


  34. RYDZEWSKI NR, Lesniak MS, Chandler JP, Kalapurakal JA, et al
    Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
    Cancer. 2017 Nov 13. doi: 10.1002/cncr.31088.
    PubMed     Text format     Abstract available


    October 2017
  35. SHEN CJ, Hu C, Ladra MM, Narang AK, et al
    Socioeconomic factors affect the selection of proton radiation therapy for children.
    Cancer. 2017;123:4048-4056.
    PubMed     Text format     Abstract available


  36. SLOOT S, Chen YA, Zhao X, Weber JL, et al
    Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.
    Cancer. 2017 Oct 12. doi: 10.1002/cncr.30946.
    PubMed     Text format     Abstract available


  37. MILLER JJ, Shih HA, Andronesi OC, Cahill DP, et al
    Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.
    Cancer. 2017 Oct 5. doi: 10.1002/cncr.31039.
    PubMed     Text format     Abstract available


    September 2017
  38. HAN CH, Batchelor TT
    Diagnosis and management of primary central nervous system lymphoma.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.30965.
    PubMed     Text format     Abstract available


  39. ARBOUR KC, Kris MG, Riely GJ, Ni A, et al
    Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.
    Cancer. 2017 Sep 21. doi: 10.1002/cncr.30990.
    PubMed     Text format     Abstract available



  40. Wearable medical device improves survival for glioblastoma patients.
    Cancer. 2017;123:3433.
    PubMed     Text format    


  41. BENZ LS, Wrensch MR, Schildkraut JM, Bondy ML, et al
    Quality of life after surgery for intracranial meningioma.
    Cancer. 2017 Sep 13. doi: 10.1002/cncr.30975.
    PubMed     Text format     Abstract available


  42. DIAO K, Sun Y, Yoo SK, Yu C, et al
    Safety-net versus private hospital setting for brain metastasis patients treated with radiosurgery alone: Disparities in follow-up care and outcomes.
    Cancer. 2017 Sep 13. doi: 10.1002/cncr.30984.
    PubMed     Text format     Abstract available


  43. BLUM MURPHY M, Xiao L, Patel VR, Maru DM, et al
    Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30953.
    PubMed     Text format     Abstract available


    July 2017
  44. WAHL M, Chang SM, Phillips JJ, Molinaro AM, et al
    Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.
    Cancer. 2017 Jul 31. doi: 10.1002/cncr.30909.
    PubMed     Text format     Abstract available


  45. FIELD KM, Phal PM, Fitt G, Goh C, et al
    The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30838.
    PubMed     Text format     Abstract available


  46. SATO M, Gunther JR, Mahajan A, Jo E, et al
    Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy.
    Cancer. 2017;123:2570-2578.
    PubMed     Text format     Abstract available


  47. ALVAREZ E, Keegan T, Johnston EE, Haile R, et al
    Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
    Cancer. 2017;123:2516-2523.
    PubMed     Text format     Abstract available


    June 2017
  48. WESTPHAL D, Glitza Oliva IC, Niessner H
    Molecular insights into melanoma brain metastases.
    Cancer. 2017;123.
    PubMed     Text format     Abstract available


  49. JOHNSON DB, Sullivan RJ, Menzies AM
    Immune checkpoint inhibitors in challenging populations.
    Cancer. 2017;123:1904-1911.
    PubMed     Text format     Abstract available


    May 2017
  50. LEHMANN V, Tuinman MA, Keim MC, Winning AM, et al
    Psychosexual development and satisfaction in long-term survivors of childhood cancer: Neurotoxic treatment intensity as a risk indicator.
    Cancer. 2017;123:1869-1876.
    PubMed     Text format     Abstract available


    April 2017
  51. AMSBAUGH MJ, Yusuf MB, Gaskins J, Burton EC, et al
    Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Database.
    Cancer. 2017 Apr 27. doi: 10.1002/cncr.30730.
    PubMed     Text format     Abstract available


  52. DEFILIPP Z, Li S, El-Jawahri A, Armand P, et al
    High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30695.
    PubMed     Text format     Abstract available


  53. KAWAMURA J, Kamoshida S, Shimakata T, Hayashi Y, et al
    Filter paper-assisted cell transfer (FaCT) technique: A novel cell-sampling technique for intraoperative diagnosis of central nervous system tumors.
    Cancer. 2017;125:277-282.
    PubMed     Text format     Abstract available


  54. YANEZ ML, Miller JJ, Batchelor TT
    Diagnosis and treatment of epidural metastases.
    Cancer. 2017;123:1106-1114.
    PubMed     Text format     Abstract available


    February 2017
  55. FISCHER-VALUCK BW, Chen I, Srivastava AJ, Floberg JM, et al
    Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database.
    Cancer. 2017;123:682-687.
    PubMed     Text format     Abstract available


  56. LANIER JC, Abrams AN
    Posterior fossa syndrome: Review of the behavioral and emotional aspects in pediatric cancer patients.
    Cancer. 2017;123:551-559.
    PubMed     Text format     Abstract available


  57. MILLER JA, Kotecha R, Ahluwalia MS, Mohammadi AM, et al
    Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
    Cancer. 2017 Feb 13. doi: 10.1002/cncr.30616.
    PubMed     Text format     Abstract available


  58. SANDLER KA, Shaverdian N, Cook RR, Kishan AU, et al
    Treatment trends for patients with brain metastases: Does practice reflect the data?
    Cancer. 2017 Feb 8. doi: 10.1002/cncr.30607.
    PubMed     Text format     Abstract available


  59. ACQUAYE AA, Vera E, Gilbert MR, Armstrong TS, et al
    Clinical presentation and outcomes for adult ependymoma patients.
    Cancer. 2017;123:494-501.
    PubMed     Text format     Abstract available


    January 2017
  60. PRINTZ C
    Device rapidly measures cell growth and can help determine drug resistance in cancer.
    Cancer. 2017;123:10-11.
    PubMed     Text format    


    November 2016
  61. DUNN-PIRIO AM, Vlahovic G
    Immunotherapy approaches in the treatment of malignant brain tumors.
    Cancer. 2016 Nov 22. doi: 10.1002/cncr.30371.
    PubMed     Text format     Abstract available


    October 2016
  62. BOELE FW, Given CW, Given BA, Donovan HS, et al
    Family caregivers' level of mastery predicts survival of patients with glioblastoma: A preliminary report.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30428.
    PubMed     Text format     Abstract available



  63. Erratum: Pallini R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, Cenci T, Pierconti F, Martini M, De Maria R and Larocca LM. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer. 2011;117:162-17
    Cancer. 2016;122:3090.
    PubMed     Text format    


    September 2016
  64. CALDARELLA A, Barchielli A
    Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
    Cancer. 2016 Sep 13. doi: 10.1002/cncr.30341.
    PubMed     Text format    


  65. GRAMATZKI D, Weller M
    Reply to glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
    Cancer. 2016 Sep 13. doi: 10.1002/cncr.30340.
    PubMed     Text format    


    August 2016
  66. SHOUSHTARI AN, Munhoz RR, Kuk D, Ott PA, et al
    The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
    Cancer. 2016 Aug 17. doi: 10.1002/cncr.30259.
    PubMed     Text format     Abstract available


    June 2016
  67. DASENBROCK HH, Devine CA, Liu KX, Gormley WB, et al
    Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis.
    Cancer. 2016;122:1708-17.
    PubMed     Text format     Abstract available


    May 2016
  68. VERMA V, Mishra MV, Mehta MP
    A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
    Cancer. 2016;122:1483-501.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: